Protocol No.: COG-ANBL2131

A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
Principal Investigator
Meyer, Ashley
Phase
III
Age Group
Both
Applicable Disease Site
Brain Cancer
Participating Institutions
Mary Babb Randolph Cancer Center
West Virginia University
Contact
Carla Corbin, RN, BSN
Nurse Clinician
Phone: +1 304-293-1217

View on ClinicalTrials.gov